loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 206724 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Natco Pharma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 BUDESONIDE (1)

    filter

    01 NATCO (1)

    filter

    01 CAPSULE, DELAYED RELEASE;ORAL (1)

    filter

    01 3MG (1)

    filter

    01 USA (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Budesonide

    PDF Supplier PDF
    URL Supplier Web Content
    CAPSULE, DELAYED RELEA...
    3MG
    BUDESONIDE
    USA
    206724
    2016-11-23
    DISCN
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for CTD TGA MCC DOSSIER APPLICATION 206724

    Looking for CTD TGA MCC DOSSIER APPLICATION 206724 1

    19

    Natco Pharma, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is BUDESONIDE, with a corresponding application number 206724 and regulatory information .

    proudly manufactured in the

    approval since 2016-11-23

    Natco Pharma's BUDESONIDE CAPSULE, DELAYED RELEASE;ORAL, medication with 3MG of BUDESONIDE.

    Post Enquiry
    POST ENQUIRY